- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Illumina Inc (ILMN)
Illumina Inc stock price live, this page displays NASDAQ ILMN stock exchange data. View the ILMN premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Illumina Inc real time stock price chart below.
What Is the Illumina Inc Stock Price Today?
The Illumina Inc stock price today is 132.26.
What Is the Stock Symbol for Illumina Inc?
The stock ticker symbol for Illumina Inc is ILMN.
Is ILMN the Same as $ILMN?
$ILMN is a common way to refer to the Illumina Inc ticker symbol in social media, forums, and online discussions. The dollar sign is a shorthand convention used to indicate that it is a stock ticker symbol
What Stock Exchange Does Illumina Inc Trade On?
Illumina Inc is listed and trades on the NASDAQ stock exchange.
Is Illumina Inc a Good Stock to Buy?
Determining whether Illumina Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess the current Illumina Inc share price compared with the fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the ILMN quote. (ISIN: US4523271090)
What Is the Illumina Inc Stock Price Today?
The Illumina Inc stock price today is 132.26.
What Is the Stock Symbol for Illumina Inc?
The stock ticker symbol for Illumina Inc is ILMN.
Is ILMN the Same as $ILMN?
$ILMN is a common way to refer to the Illumina Inc ticker symbol in social media, forums, and online discussions. The dollar sign is a shorthand convention used to indicate that it is a stock ticker symbol
What Stock Exchange Does Illumina Inc Trade On?
Illumina Inc is listed and trades on the NASDAQ stock exchange.
Is Illumina Inc a Good Stock to Buy?
Determining whether Illumina Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess the current Illumina Inc share price compared with the fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the ILMN quote. (ISIN: US4523271090)
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
130.20
133.37
52 wk Range
69.83
155.53
Earnings results expected in 15 days
1/2
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
130.20133.37
52 wk Range
69.83155.53
Key Statistics
Edit
Prev. Close
Open
Volume
Average Vol. (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Vol. (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
ILMN Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Price Target
136.11
Upside
+2.91%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Valuation implies a poor free cash flow yield
- Form DEF 14A Illumina For: 9 April
- Investing.com
- Form DEF 14A Illumina For: 9 April
- Investing.com
- Form PRE 14A Illumina Inc For: 6 April
- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy
Illumina, Inc. provides sequencing- and array-based solutions for genetic and genomic analysis in the Americas, Europe, Greater China, the Asia Pacific, the Middle East, and Africa. The company offers sequencing- and array-based instruments and consumables, which include reagents, flow cells, and library preparation; whole-genome sequencing kits, which sequence entire genomes of various size and complexity; and targeted resequencing kits, which sequence exomes, specific genes, and RNA or other genomic regions of interest. It also provides whole-genome sequencing, genotyping, noninvasive prenatal testing, and product support services. The company serves genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies. The company markets and distributes its products directly to customers, as well as through life-science distributors. The company has a collaboration with Labcorp Holdings Inc. for the development of oncology treatments through applications of sequencing solutions across the healthcare ecosystem. It also has a data partnership with Center for Data-Driven Discovery in Biomedicine to advance research in pediatric cancer and rare disease. Illumina, Inc. was incorporated in 1998 and is headquartered in San Diego, California.
Illumina Inc SWOT Analysis
Strategic Opportunities | Learn about Illumina's potential for growth in clinical sequencing and how cost-cutting measures could improve profitability amidst geopolitical uncertainties |
Financial Crossroads | Analyst targets range from $80 to $185, reflecting diverse views on Illumina's profitability potential and ability to navigate current market headwinds |
Market Dynamics | Explore Illumina's position in the genomics field, its innovative technologies, and the increasing competition from rivals like Roche in the clinical market |
Genomic Giant's Hurdles | Illumina faces significant challenges, including China market issues and competitive pressures, impacting its financial outlook and stock performance |
Illumina Inc Earnings Call Summary for Q4/2025
- Illumina exceeded Q4 2025 expectations with EPS of $1.35 (10.66% above forecast) and revenue of $1.16 billion (5% YoY growth), though stock declined 0.25% in after-hours trading
- Strong financial performance included $267 million in Q4 free cash flow, $931 million for the year, and $740 million returned to shareholders through repurchases
- Clinical sequencing market showed robust growth while research segment faced funding challenges; company completed strategic acquisition and launched new products
- CEO Jacob Thaysen highlighted return to growth with ex-China revenue up 7% in Q4; company focusing on strategic positioning as market evolves
- 2026 guidance projects 2-4% organic revenue growth (excluding China), total revenue of $4.5-$4.6 billion, operating margins of 23.3-23.5%, and EPS of $5.05-$5.20
Last Updated: 02/05/2026, 05:50 PM
Read Full TranscriptIllumina investor slides for Q4/2025
Last Update: Feb 05, 2026
See full investor slides
Compare ILMN to Peers and Sector
Metrics to compare | ILMN | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipILMNPeersSector | |
|---|---|---|---|---|
P/E Ratio | 0.0x | −1.0x | −0.5x | |
PEG Ratio | 0.13 | 0.03 | 0.00 | |
Price / Book | 0.0x | 0.8x | 2.6x | |
Price / LTM Sales | 0.0x | 2.9x | 3.2x | |
Upside (Analyst Target) | 13.9% | 70.2% | 47.6% | |
Fair Value Upside | Unlock | 30.0% | 6.1% | Unlock |
Analyst Ratings
9 Buy
7 Hold
3 Sell
Ratings:
19 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 136.11
(+2.91% Upside)
Earnings
Latest Release
Feb 05, 2026
EPS / Forecast
1.35 / 1.22
Revenue / Forecast
1.16B / 1.1B
People Also Watch
FAQ
What Is the Illumina (ILMN) Stock Price Today?
The Illumina stock price today is 132.26 USD.
What Stock Exchange Does Illumina Trade On?
Illumina is listed and trades on the Nasdaq Stock Exchange.
What Is the Stock Symbol for Illumina?
The stock symbol for Illumina is "ILMN."
What Is the Illumina Market Cap?
As of today, Illumina market cap is 21.06B USD.
What Is Illumina's Earnings Per Share (TTM)?
The Illumina EPS (TTM) is 5.45.
When Is the Next Illumina Earnings Date?
Illumina will release its next earnings report on Apr 30, 2026.
From a Technical Analysis Perspective, Is ILMN a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has Illumina Stock Split?
Illumina has split 1 times.
How Many Employees Does Illumina Have?
Illumina has 8625 employees.
What is the current trading status of Illumina (ILMN)?
As of Apr 15, 2026, Illumina (ILMN) is trading at a price of 132.26 USD, with a previous close of 130.32 USD. The stock has fluctuated within a day range of 130.20 USD to 133.37 USD, while its 52-week range spans from 69.83 USD to 155.53 USD.
What Is Illumina (ILMN) Price Target According to Analysts?
The average 12-month price target for Illumina is 136.11 USD, with a high estimate of 170 USD and a low estimate of 80 USD. 9 analysts recommend buying the stock, while 3 suggest selling, leading to an overall rating of Buy. The stock has an +2.91% Upside potential.
What Is the ILMN Premarket Price?
ILMN's last pre-market stock price is 129.69 USD. The pre-market share volume is 150.00, and the stock has decreased by -0.63, or -0.48%.
What Is the ILMN After Hours Price?
ILMN's last after hours stock price is 132.21 USD, the stock has decreased by -0.05, or -0.04%.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.